AI Article Synopsis
- LncRNA FEZF1-AS1 is identified as an oncogene that is significantly upregulated in glioblastoma (GBM) and associated with poorer survival rates.
- The study involved analyzing tissue samples and using various assays to explore the interactions between FEZF1-AS1, miR-34a, and Notch-1, revealing FEZF1-AS1's role in increasing GBM cell invasion and migration.
- The findings suggest that FEZF1-AS1 may act as a sponge for miR-34a, leading to the upregulation of Notch-1, which enhances the invasive properties of GBM cells.
Article Abstract
Introduction: LncRNA FEZF1-AS1 has been reported to be an oncogene in many types of cancer, while its role in glioblastoma (GBM) is unknown. This study aimed to investigate the potential involvement of FEZF1-AS1 in GBM.
Methods: FEZF1-AS1 expression in paired GBM and non-tumor tissues from GBM patients was determined by RT-qPCR. A 2-year follow-up was performed to analyze the prognostic value of FEZF1-AS1 for GBM. Cell transfections were performed to analyze the interactions between FEZF1-AS1, miR-34a and Notch-1. Transwell assay was performed to analyze the role of FEZF1-AS1, miR-34a and Notch-1 in regulating GBM cell invasion and migration.
Results: In this study, analysis of TCGA dataset revealed the upregulation of FEZF1-AS1 in GBM, and the overexpression of FEZF1-AS1 in GBM was further confirmed using GBM tissues from GBM patients included in this study. High levels of FEZF1-AS1 were correlated with poor survival. FEZF1-AS1 was predicted to form base pairing with miR-34a. However, overexpression of FEZF1-AS1 and miR-34a failed to affect the expression of each other. However, upregulation of Notch-1, a target of miR-34a, was observed after FEZF1-AS1 in GBM cells. Moreover, increased invasion and migration rates of GBM cells were observed after FEZF1-AS1 and Notch-1 overexpression. MiR-34a played an opposite role and reduced the effects of FEZF1-AS1 and Notch-1 overexpression.
Conclusion: FEZF1-AS1 may sponge miR-34a to upregulate Notch-1 in GBM, thereby promoting cancer cell invasion and migration.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075242 | PMC |
| http://dx.doi.org/10.2147/CMAR.S240531 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
Neurosci Lett
November 2021
Department of Neurosurgery, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang 330038, Jiangxi, China. Electronic address:
Objectives: Glioblastoma (GBM) represents the commonest malignant glioma. Long non-coding RNA (lncRNA) FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) has been validated to play an oncogenic role in multiple human malignancies, while its function in GBM has not been largely reported. We aim to identify the regulatory mechanism of FEZF1-AS1 in GBM.
View Article and Find Full Text PDFLncRNA FEZF1-AS1 Sponges miR-34a to Upregulate Notch-1 in Glioblastoma.
Cancer Manag Res
March 2020
Department of Neurosurgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province 510630, People's Republic of China.
Article Synopsis
- LncRNA FEZF1-AS1 is identified as an oncogene that is significantly upregulated in glioblastoma (GBM) and associated with poorer survival rates.
- The study involved analyzing tissue samples and using various assays to explore the interactions between FEZF1-AS1, miR-34a, and Notch-1, revealing FEZF1-AS1's role in increasing GBM cell invasion and migration.
- The findings suggest that FEZF1-AS1 may act as a sponge for miR-34a, leading to the upregulation of Notch-1, which enhances the invasive properties of GBM cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!